<DOC>
	<DOC>NCT00293878</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and effects on lipids of FM-VP4 administered for 12 weeks in subjects with mild to moderate primary hypercholesterolemia.</brief_summary>
	<brief_title>Study on the Safety and Effects on Lipids of FM-VP4 in Subjects With Primary Hypercholesterolemia</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<criteria>Mild to moderate primary hypercholesterolemia Able to give informed consent and to comply with study procedures (including diet) Homozygous familial hypercholesterolemia Age &lt;18 or &gt;75 years Pregnant women or women of childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2007</verification_date>
</DOC>